BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia Vera without symptomatic splenomegaly.
BESREMi® 250 micrograms/0.5 mL solution for injection in pre-filled pen
BESREMi® 500 micrograms/0.5 mL solution for injection in pre-filled pen
Ropeginterferon alfa-2b